News Daily News CTO PCI Reduces Symptoms, Improves Quality of Life: Meta-Analysis Michael O'Riordan April 09, 2026
News Conference News ACC 2026 DIG-RHD: Digoxin Effective in Rheumatic Heart Disease Michael O'Riordan April 06, 2026
News Conference News ACC 2026 Olezarsen Doesn’t Lower Plaque Volume: Essence-TIMI 73b Yael L. Maxwell April 01, 2026
News Conference News ACC 2026 GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’ L.A. McKeown March 31, 2026
News Conference News ACC 2026 SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients Michael O'Riordan March 30, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE Yael L. Maxwell March 28, 2026
News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide L.A. McKeown March 19, 2026
News Daily News Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA Yael L. Maxwell March 16, 2026
News Daily News Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis Yael L. Maxwell March 12, 2026
News Conference News CRT 2026 DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients L.A. McKeown March 09, 2026
News Daily News Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone Michael O'Riordan March 03, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2026 Michael O'Riordan March 02, 2026
News Conference News ISC 2026 Loberamisal Scores a Rare Win for Stroke Neuroprotection Todd Neale February 12, 2026
News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
News Conference News ISC 2026 OPTION: IV Tenecteplase Boosts Outcomes Late After Non-LVO Stroke Todd Neale February 11, 2026
News Daily News Q&A: Lior Jankelson on AI Tools for Suspected ACS and More Todd Neale February 10, 2026
News Conference News ISC 2026 CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy Todd Neale February 06, 2026
News Daily News Nearly 150 Million US Adults Eligible for CKM Syndrome Meds Caitlin E. Cox February 02, 2026